The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Predicting drug metabolism: experiment and/or computation?
Open accessAbstract
Drug metabolism can produce metabolites with physicochemical and pharmacological properties that differ substantially from those of the parent drug, and consequently has important implications for both drug safety and efficacy. To reduce the risk of costly clinical-stage attrition due to the metabolic characteristics of drug candidates, there is a need for efficient and reliable ways to predict drug metabolism in vitro, in silico and in vivo. In this Perspective, we provide an overview of the state of the art of experimental and computational approaches for investigating drug metabolism. We highlight the scope and limitations of these methods, and indicate strategies to harvest the synergies that result from combining measurement and prediction of drug metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
KEGG for integration and interpretation of large-scale molecular data sets
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., & Tanabe, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr988 · Cited by 4,848
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Warshel, A., & Levitt, M. (1976) · Journal of Molecular Biology · doi:10.1016/0022-2836(76)90311-9 · Cited by 4,479
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
Statistical Mechanics of Fluid Mixtures
Kirkwood, J. G. (1935) · The Journal of Chemical Physics · doi:10.1063/1.1749657 · Cited by 3,454
HMDB: the Human Metabolome Database
Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl923 · Cited by 3,231
High-Temperature Equation of State by a Perturbation Method. I. Nonpolar Gases
Zwanzig, R. W. (1954) · The Journal of Chemical Physics · doi:10.1063/1.1740409 · Cited by 3,066
Efficient estimation of free energy differences from Monte Carlo data
Bennett, C. H. (1976) · Journal of Computational Physics · doi:10.1016/0021-9991(76)90078-4 · Cited by 2,755
Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,634
METLIN—a metabolite mass spectral database
Smith, C. A., Maille, G. O., Want, E. J., Qin, C., Trauger, S. A., Brandon, T. R., Custodio, D. E., Abagyan, R., & Siuzdak, G. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000179845.53213.39 · Cited by 2,226
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities
Liu, T., Lin, Y., Wen, X., Jorissen, R. N., & Gilson, M. K. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl999 · Cited by 2,124
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born
Götz, A. W., Williamson, M. J., Xu, D., Poole, D., Le Grand, S., & Walker, R. C. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct200909j · Cited by 2,046
Nicholson, J. K., & Lindon, J. C. (2008) · Nature · doi:10.1038/4551054a · Cited by 1,886
A Critical Assessment of Docking Programs and Scoring Functions
Warren, G. L., Andrews, C. W., Capelli, A.-M., Clarke, B., LaLonde, J., Lambert, M. H., Lindvall, M., Nevins, N., Semus, S. F., Senger, S., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050362n · Cited by 1,814
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,630
Microscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219
A new method for predicting binding affinity in computer-aided drug design
Åqvist, J., Medina, C., & Samuelsson, J.-E. (1994) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/7.3.385 · Cited by 1,184
Comprehensive medicinal chemistry
Timmerman, H., Bast, A., Van der Goot, H., Vermeulen, N. P. E., & Zeelen, F. J. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90535-z · Cited by 1,163
Fragmentation Methods: A Route to Accurate Calculations on Large Systems
Gordon, M. S., Fedorov, D. G., Pruitt, S. R., & Slipchenko, L. V. (2012) · Chemical Reviews · doi:10.1021/cr200093j · Cited by 1,106
P450 Enzymes: Their Structure, Reactivity, and Selectivity—Modeled by QM/MM Calculations
Shaik, S., Cohen, S., Wang, Y., Chen, H., Kumar, D., & Thiel, W. (2010) · Chemical Reviews · doi:10.1021/cr900121s · Cited by 1,083
Ligand Binding: Molecular Mechanics Calculation of the Streptavidin-Biotin Rupture Force
Grubmüller, H., Heymann, B., & Tavan, P. (1996) · Science · doi:10.1126/science.271.5251.997 · Cited by 934
Ufimtsev, I. S., & Martinez, T. J. (2009) · Journal of Chemical Theory and Computation · doi:10.1021/ct9003004 · Cited by 916
Predicting in vivo drug interactions from in vitro drug discovery data
Wienkers, L. C., & Heath, T. G. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1851 · Cited by 904
Crystal structure of human cytochrome P450 2C9 with bound warfarin
Williams, P. A., Cosme, J., Ward, A., Angove, H. C., Matak Vinković, D., & Jhoti, H. (2003) · Nature · doi:10.1038/nature01862 · Cited by 821
In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
Ekins, S., Mestres, J., & Testa, B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707305 · Cited by 703
Self-citationStepan, A. F., Walker, D. P., Bauman, J., Price, D. A., Baillie, T. A., Kalgutkar, A. S., & Aleo, M. D. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200168d · Cited by 698
hERG K+Channels: Structure, Function, and Clinical Significance
Vandenberg, J. I., Perry, M. D., Perrin, M. J., Mann, S. A., Ke, Y., & Hill, A. P. (2012) · Physiological Reviews · doi:10.1152/physrev.00036.2011 · Cited by 696
An evaluation of the implementation of the Cramer classification scheme in the Toxtree software
Patlewicz, G., Jeliazkova, N., Safford, R. J., Worth, A. P., & Aleksiev, B. (2008) · SAR and QSAR in Environmental Research · doi:10.1080/10629360802083871 · Cited by 512
Prodrugs—from Serendipity to Rational Design
Huttunen, K. M., Raunio, H., & Rautio, J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003459 · Cited by 505
MetaSite: Understanding Metabolism in Human Cytochromes from the Perspective of the Chemist
Cruciani, G., Carosati, E., De Boeck, B., Ethirajulu, K., Mackie, C., Howe, T., & Vianello, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050529c · Cited by 496
PharmGKB: the Pharmacogenetics Knowledge Base
Hewett, M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.163 · Cited by 428
Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity
Gillman, P. K. (2005) · British Journal of Anaesthesia · doi:10.1093/bja/aei210 · Cited by 397
Lessons Learned from Marketed and Investigational Prodrugs
Ettmayer, P., Amidon, G. L., Clement, B., & Testa, B. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0303812 · Cited by 384
Self-citationThe ins and outs of cytochrome P450s
Cojocaru, V., Winn, P. J., & Wade, R. C. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.07.005 · Cited by 363
The University of Minnesota Biocatalysis/Biodegradation Database: improving public access
Gao, J., Ellis, L. B. M., & Wackett, L. P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp771 · Cited by 347
Marchant, C. A., Briggs, K. A., & Long, A. (2008) · Toxicology Mechanisms and Methods · doi:10.1080/15376510701857320 · Cited by 341
PocketPicker: analysis of ligand binding-sites with shape descriptors
Weisel, M., Proschak, E., & Schneider, G. (2007) · Chemistry Central Journal · doi:10.1186/1752-153x-1-7 · Cited by 341
Self-citationSMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism
Rydberg, P., Gloriam, D. E., Zaretzki, J., Breneman, C., & Olsen, L. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100016x · Cited by 327
Lüdemann, S. K., Lounnas, V., & Wade, R. C. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4154 · Cited by 326
Sivaraman, A., Leach, J., Townsend, S., Iida, T., Hogan, B., Stolz, D., Fry, R., Samson, L., Tannenbaum, S., & Griffith, L. (2005) · Current Drug Metabolism · doi:10.2174/138920005774832632 · Cited by 310
Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms
Kirchmair, J., Williamson, M. J., Tyzack, J. D., Tan, L., Bond, P. J., Bender, A., & Glen, R. C. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200542m · Cited by 289
Self-citationKoutsoukas, A., Simms, B., Kirchmair, J., Bond, P. J., Whitmore, A. V., Zimmer, S., Young, M. P., Jenkins, J. L., Glick, M., Glen, R. C., et al. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.011 · Cited by 287
Self-citationAdvances in metabolite identification
Wishart, D. S. (2011) · Bioanalysis · doi:10.4155/bio.11.155 · Cited by 284
Preissner, S., Kroll, K., Dunkel, M., Senger, C., Goldsobel, G., Kuzman, D., Guenther, S., Winnenburg, R., Schroeder, M., & Preissner, R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp970 · Cited by 274
Reactions and enzymes in the metabolism of drugs and other xenobiotics
Testa, B., Pedretti, A., & Vistoli, G. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.01.017 · Cited by 254
NMR Spectroscopy in Pharmaceutical Analysis
(2008) · Elsevier eBooks · doi:10.1016/b978-0-444-53173-5.x0001-7 · Cited by 248
Soft drug design: General principles and recent applications
Bodor, N., & Buchwald, P. (2000) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(200001)20:1<58::aid-med3>3.0.co;2-x · Cited by 239
Jacobsen, W., Kuhn, B., Soldner, A., Kirchner, G., Sewing, K.-F., Kollman, P. A., Benet, L. Z., & Christians, U. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15086-6 · Cited by 236
The Signature Molecular Descriptor. 1. Using Extended Valence Sequences in QSAR and QSPR Studies
Faulon, J.-L., Visco, D. P., & Pophale, R. S. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci020345w · Cited by 232
Applying Mechanisms of Chemical Toxicity to Predict Drug Safety
Guengerich, F. P., & MacDonald, J. S. (2007) · Chemical Research in Toxicology · doi:10.1021/tx600260a · Cited by 231
Reker, D., Rodrigues, T., Schneider, P., & Schneider, G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320001111 · Cited by 227
Self-citationDrug Metabolite Profiling and Identification by High-resolution Mass Spectrometry
Zhu, M., Zhang, H., & Humphreys, W. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.200055 · Cited by 214
The role of drug metabolizing enzymes in clearance
Di, L. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.876006 · Cited by 206
SyGMa: Combining Expert Knowledge and Empirical Scoring in the Prediction of Metabolites
Ridder, L., & Wagener, M. (2008) · ChemMedChem · doi:10.1002/cmdc.200700312 · Cited by 181
META. 1. A Program for the Evaluation of Metabolic Transformation of Chemicals
Klopman, G., Dimayuga, M., & Talafous, J. (1994) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00022a014 · Cited by 169
Pharmacologically Active Drug Metabolites: Impact on Drug Discovery and Pharmacotherapy
Obach, R. S. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005439 · Cited by 159
Kell, D. B., Dobson, P. D., Bilsland, E., & Oliver, S. G. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.11.008 · Cited by 154
The SMARTCyp cytochrome P450 metabolism prediction server
Rydberg, P., Gloriam, D. E. I., & Olsen, L. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq584 · Cited by 153
van Waterschoot, R. A. B., & Schinkel, A. H. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002584 · Cited by 151
Fura, A., Shu, Y., Zhu, M., Hanson, R. L., Roongta, V. A., & Humphreys, W. G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040066v · Cited by 151
Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms
Ekins, S., Bugrim, A. E., Brovold, L., Kirillov, E., Nikolsky, Y., Rakhmatulin, E. A., Sorokina, S. Y., Ryabov, A., Serebryiskaya, T., Melnikov, A., et al. (2006) · Xenobiotica · doi:10.1080/00498250600861660 · Cited by 150
The signature molecular descriptor
Churchwell, C. J., Rintoul, M. D., Martin, S., Visco, D. P., Kotu, A., Larson, R. S., Sillerud, L. O., Brown, D. C., & Faulon, J. (2003) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2003.10.002 · Cited by 142
Testa, B., & Krämer, S. D. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790169 · Cited by 139
Self-citationMa, S., & Zhu, M. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.09.014 · Cited by 137
Anari, M. R., Sánchez, R. I., Bakhtiar, R., Franklin, R. B., & Baillie, T. A. (2003) · Analytical Chemistry · doi:10.1021/ac034980s · Cited by 137
Mekenyan, O. G., Dimitrov, S. D., Pavlov, T. S., & Veith, G. D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452596 · Cited by 135
Skopalík, J., Anzenbacher, P., & Otyepka, M. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp800311c · Cited by 128
A COMBINED APPROACH TO DRUG METABOLISM AND TOXICITY ASSESSMENT
Ekins, S., Andreyev, S., Ryabov, A., Kirillov, E., Rakhmatulin, E. A., Sorokina, S. Y., Bugrim, A. E., & Nikolskaya, T. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008458 · Cited by 117
Microfluidic devices for in vitro studies on liver drug metabolism and toxicity
van Midwoud, P. M., Verpoorte, E., & Groothuis, G. M. M. (2011) · Integrative Biology · doi:10.1039/c0ib00119h · Cited by 115
The University of Minnesota Pathway Prediction System: multi-level prediction and visualization
Gao, J., Ellis, L. B. M., & Wackett, L. P. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr200 · Cited by 113
Emerging Methods for Ensemble-Based Virtual Screening
Amaro, R. E., & Li, W. W. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790232279 · Cited by 111
Vedani, A., Dobler, M., & Smieško, M. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.03.018 · Cited by 109
Cao, D., Wang, J., Zhou, R., Li, Y., Yu, H., & Hou, T. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300112j · Cited by 105
The Biochemistry of Drug Metabolism – An Introduction
Testa, B., & Krämer, S. D. (2006) · Chemistry & Biodiversity · doi:10.1002/cbdv.200690111 · Cited by 104
Self-citationProdrugs: bridging pharmacodynamic/pharmacokinetic gaps
Testa, B. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.620 · Cited by 98
Self-citationZaretzki, J. M., Bergeron, C., Rydberg, P., Huang, T.-W., Bennett, K. P., & Breneman, C. M. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2000488 · Cited by 95
Hennemann, M., Friedl, A., Lobell, M., Keldenich, J., Hillisch, A., Clark, T., & Göller, A. H. (2009) · ChemMedChem · doi:10.1002/cmdc.200800384 · Cited by 95
Self-citationThe Challenges Involved in Modeling Toxicity Data In Silico: A Review
Gleeson, M. P., Modi, S. P., Bender, A., Robinson, R. M., Kirchmair, J., Promkatkaew, M., Hannongbua, S., & Glen, R. C. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799436359 · Cited by 94
Self-citationBonn, B., Leandersson, C., Fontaine, F., & Zamora, I. (2010) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.4753 · Cited by 94
Ligand-Based Models for the Isoform Specificity of Cytochrome P450 3A4, 2D6, and 2C9 Substrates
Terfloth, L., Bienfait, B., & Gasteiger, J. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700010t · Cited by 93
Ridder, L., Rietjens, I. M. C. M., Vervoort, J. J. M., & Mulholland, A. J. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0256360 · Cited by 82
IDSite: An Accurate Approach to Predict P450-Mediated Drug Metabolism
Li, J., Schneebeli, S. T., Bylund, J. H., Farid, R., & Friesner, R. A. (2011) · Journal of Chemical Theory and Computation · doi:10.1021/ct200462q · Cited by 79
Tang, W., & Lu, A. Y. H. (2009) · Drug Metabolism Reviews · doi:10.3109/03602530903401658 · Cited by 78
Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule
Mishra, N. K., Agarwal, S., & Raghava, G. P. S. (2010) · BMC Pharmacology · doi:10.1186/1471-2210-10-8 · Cited by 77
Kirchmair, J., Williamson, M. J., Afzal, A. M., Tyzack, J. D., Choy, A. P. K., Howlett, A., Rydberg, P., & Glen, R. C. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400503s · Cited by 74
Self-citationDear, G. J., Muñoz, J. A., Beaumont, C., Roberts, A., Kirk, J. M., Williams, J. P., & Campuzano, I. D. G. (2010) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.4742 · Cited by 73
Giri, S., Krausz, K. W., Idle, J. R., & Gonzalez, F. J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.10.017 · Cited by 72
WhichCyp: prediction of cytochromes P450 inhibition
Rostkowski, M., Spjuth, O., & Rydberg, P. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt325 · Cited by 71
Estimating Error Rates in Bioactivity Databases
Tiikkainen, P., Bellis, L. J., Light, Y., & Franke, L. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400099q · Cited by 70
Sykes, M. J., McKinnon, R. A., & Miners, J. O. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009793 · Cited by 70
Linezolid and Serotonin Syndrome
Quinn, D. K., & Stern, T. A. (2009) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.09r00853 · Cited by 68
Predicting Drug Metabolism by Cytochrome P450 2C9: Comparison with the 2D6 and 3A4 Isoforms
Rydberg, P., & Olsen, L. (2012) · ChemMedChem · doi:10.1002/cmdc.201200160 · Cited by 56
Hendrychova, T., Berka, K., Navrátilová, V., Anzenbacher, P., & Otyepka, M. (2012) · Current Drug Metabolism · doi:10.2174/138920012798918408 · Cited by 53
Metabolexpert: An Expert System for Predicting Metabolism of Substances
Darvas, F. (1987) · Springer eBooks · doi:10.1007/978-94-009-3937-0_7 · Cited by 50
Scheer, N., & Wolf, C. R. (2013) · Xenobiotica · doi:10.3109/00498254.2013.815831 · Cited by 50
The Contribution of Atom Accessibility to Site of Metabolism Models for Cytochromes P450
Rydberg, P., Rostkowski, M., Gloriam, D. E. I., & Olsen, L. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005116 · Cited by 49
How do metabolites differ from their parent molecules and how are they excreted?
Kirchmair, J., Howlett, A., Peironcely, J. E., Murrell, D. S., Williamson, M. J., Adams, S. E., Hankemeier, T., van Buren, L., Duchateau, G., Klaffke, W., et al. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci300487z · Cited by 43
Self-citationDiet and Monoamine Oxidase Inhibitors: A Re-Examination
Sullivan, E. A., & Shulman, K. I. (1984) · The Canadian Journal of Psychiatry · doi:10.1177/070674378402900814 · Cited by 40
Kitamura, S., & Sugihara, K. (2014) · Xenobiotica · doi:10.3109/00498254.2013.868062 · Cited by 38
Bowman, A. L., Ridder, L., Rietjens, I. M. C. M., Vervoort, J. J. M., & Mulholland, A. J. (2007) · Biochemistry · doi:10.1021/bi0622827 · Cited by 38
Molecular Similarity and Xenobiotic Metabolism
Adams, S. (2010) · doi:10.17863/cam.16274 · Cited by 36
Drug Metabolism for the Perplexed Medicinal Chemist
Testa, B. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900052 · Cited by 32
Self-citationComputational Profiling of Bioactive Compounds Using a Target-Dependent Composite Workflow
Meslamani, J. E., Bhajun, R., Martz, F., & Rognan, D. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400303n · Cited by 32
Ion Mobility Spectrometry–Mass Spectrometry Analysis for the Site of Aromatic Hydroxylation
Shimizu, A., & Chiba, M. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.051953 · Cited by 20
Organic Stereochemistry. Part 8
Testa, B. (2013) · Helvetica Chimica Acta · doi:10.1002/hlca.201200476 · Cited by 13
Self-citationShaik, S. S., Chen, H., Usharani, D., & Thiel, W. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673261.ch06 · Cited by 11
Isotopic enrichment enhancement in metabonomic analysis of UPLC–MS data sets
Athersuch, T. J., Nicholson, J. K., & Wilson, I. D. (2007) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1217 · Cited by 9
Self-citationEsser, C. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00282-0 · Cited by 8
Organic Stereochemistry. Part 7
Testa, B. (2013) · Helvetica Chimica Acta · doi:10.1002/hlca.201200475 · Cited by 7
Self-citationKnowledge‐Based Approaches for Predicting the Sites and Products of Metabolism
Judson, P. N. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673261.ch12 · Cited by 6
Cytochrome P450 Substrate Recognition and Binding
Leach, A. G., & Kidley, N. J. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673261.ch05 · Cited by 5
Online Databases and Web Servers for Drug Metabolism Research
Wishart, D. S. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673261.ch03 · Cited by 5
Wilson, I. D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-444-53173-5.00019-6 · Cited by 5
Self-citationIn VitroApproaches to Study Drug–Drug Interactions
Ferguson, S., & Bonzo, J. A. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673261.ch18 · Cited by 2
Prediction of Phosphoglycoprotein (P‐gp)‐Mediated Disposition in Early Drug Discovery
Thomas, S., & Dimelow, R. J. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673261.ch15 · Cited by 2
Pharmacophore‐Based Methods for Predicting the Inhibition and Induction of Metabolic Enzymes
Kaserer, T., Temml, V., & Schuster, D. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673261.ch14 · Cited by 2
Cited by
Daina, A., Michielin, O., & Zoete, V. (2017) · Scientific Reports · doi:10.1038/srep42717 · Cited by 18,367
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Counting on natural products for drug design
Rodrigues, T., Reker, D., Schneider, P., & Schneider, G. (2016) · Nature Chemistry · doi:10.1038/nchem.2479 · Cited by 1,250
Self-citationNatural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,241
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
Self-citation
Metadata
- Authors
- Kirchmair, J., Göller, A. H., Lang, D., Kunze, J., Testa, B., Wilson, I. D., Glen, R. C., & Schneider, G.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-04-24
- Volume
- 14
- Issue
- 6
- Pages
- 387-404
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2069457036
- Cited by
- 502
- References
- 118
- FWCI
- 12.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.